Reconstructive plastic surgery for pancreatic cancer: quality or quantity?
Aim. Study of the influence of reconstructive plastic technologies of surgical treatment of pancreatic cancer on the life expectancy of patients and its quality. Materials and methods. The analysis of the short and long-term outcomes of surgical treatment of pancreatic cancer was made. In total, radical operations were performed in 32 patients, including 14 men and 18 women aged from 51 to 73 (56,5±4,8) years. Pilorussus-preserving pancreatoduodenal resection was performed in 20 (62,5%) patients, gastropancreatoduodenal resection - in 6 (18,75%), proximal - 5 (15,6%) and in one patient (3,1%) - distal resection of the pancreas. Patients were formed areflux pancreatojejunostomy according to the method of the clinic. Results. Hospital mortality was 6,25%. More than three years after surgery, 26,7% of patients are alive, the median survival rate is 19,5±2,4 months. An assessment of the quality of life and the function of the formed pancreatojejunostomy conducted in the immediate and remote periods showed that the presence of an reflux valve reliably prevents the development of pancreatic pancreatic stump, providing a high level of quality of life for patients. Conclusions. The use of organ-preserving and organomodulating technologies in the treatment of operable pancreatic cancer does not affect survival, but provides an acceptable level of quality of life for patients in the short and long term after surgery.